• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
4,942 results

Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.

Docket 23-1247, U.S. Court of Appeals, Federal Circuit (Dec. 15, 2022)
Patent - Abbreviated New Drug Application (ANDA)
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
Plaintiff - Appellant VANDA PHARMACEUTICALS INC.
Defendant - Appellee TEVA PHARMACEUTICALS USA, INC.
Defendant - Appellee APOTEX INC.
...
cite Cite Docket
Analyze

Acuitas Therapeutics Inc. v. GlaxoSmithKline Biologicals SA et al

Docket 1:25-cv-00003, Delaware District Court (Jan. 2, 2025)
Judge Gregory B. Williams, presiding
Patent
DivisionWilmington
FlagsPATENT
Cause28:2201 Declaratory Judgment
Case Type830 Patent
Tags830 Patent, 830 Patent
DeadlineSO ORDERED, re 14 STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including April 23, 2025 filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC., answer due 4/23/2025., STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including April 23, 2025 - filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC.
Plaintiff Acuitas Therapeutics Inc.
Defendant GlaxoSmithKline Biologicals SA
Defendant GlaxoSmithKline LLC
cite Cite Docket
Analyze

Baxalta Incorporated v. Genentech, Inc.

Docket 22-1461, U.S. Court of Appeals, Federal Circuit (Feb. 10, 2022)
TARANTO, presiding.
Patent
11/15/2022
11/15/2022 32 Notice from Appellee Genentech, Inc. regarding conflicts with oral argument. None. Service: 11/15/2022 by email. [884269] [22-1461] [Eric Stone] [En...
cite Cite Docket
Analyze

Acuitas Therapeutics Inc. et al v. Alnylam Pharmaceuticals, Inc.

Docket 1:24-cv-00816, Delaware District Court (July 12, 2024)
Judge Colm F. Connolly, presiding
Patent
DivisionWilmington
FlagsPATENT
Cause35:1 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff Acuitas Therapeutics Inc.
Plaintiff Michael J. Hope
Plaintiff Steven M Ansell
...
cite Cite Docket
Analyze

Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al

Docket 1:23-cv-01459, Delaware District Court (Dec. 21, 2023)
Judge Colm F. Connolly, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsPATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineExpert Discovery due by 9/5/2025.
DeadlineProposed Pretrial Order due by 11/3/2025.
Plaintiff Novo Nordisk Inc.
Plaintiff Novo Nordisk A/S
Defendant Sun Pharmaceutical Industries Ltd.
...
cite Cite Docket
Analyze

Acuitas Therapeutics, Inc. et al v. CureVac SE

Docket 2:23-cv-00610, Virginia Eastern District Court (Nov. 13, 2023)
District Judge Jamar K. Walker, presiding, Magistrate Judge Douglas E. Miller
Patent

cite Cite Docket
Analyze

CureVac SE, et al. v. BioNTech SE, et al.

Docket 2:23-cv-00222, Virginia Eastern District Court (May 19, 2023)
District Judge Jamar K. Walker, presiding, Magistrate Judge Douglas E. Miller
Patent

cite Cite Docket
Analyze

Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.

Docket 1:23-cv-00101, Delaware District Court (Jan. 27, 2023)
Judge Colm F. Connolly, presiding.
Patent - Abbreviated New Drug Application (ANDA)

cite Cite Docket
Analyze
1 2 3 4 5 ... >>